TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›TRMK›Financials
Annual statements · SEC XBRL · FY2016 – FY2025

TRUSTMARK CORP (TRMK) financials

Income statement

TRUSTMARK CORP (TRMK) income statement, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income$108M$106M$150M$150M$160M$147M$71.9M$165M$223M$224M
EPS (diluted)$1.60$1.56$2.21$2.32$2.51$2.34$1.17$2.70$3.63$3.70

Cash flow

TRUSTMARK CORP (TRMK) cash flow, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$148M$207M$239M$116M$65.3M$349M$297M$197M$117M$244M
Capital expenditures$10.2M$13.2M$14.6M$17.3M$22.6M$27.4M$26.6M$40.1M$23.5M$11.9M
Free cash flow$138M$193M$225M$99.1M$42.8M$321M$270M$157M$93.4M$232M
Share buybacks$750K$0.00$62.4M$56.6M$27.5M$61.8M$24.6M$0.00$7.50M$80.0M
Dividends paid$62.7M$62.8M$62.4M$59.8M$58.8M$58.1M$56.7M$56.7M$56.8M$58.5M

Balance sheet

TRUSTMARK CORP (TRMK) balance sheet, annual, from SEC filings
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$328M$336M$350M———————
Total assets$13.4B$13.8B$13.3B$13.5B$16.6B$17.6B$18.0B$18.7B$18.2B$18.9B
Total liabilities$11.8B$12.2B$11.7B$11.8B$14.8B$15.9B$16.5B$17.1B$16.2B$16.8B
Shareholders' equity$1.52B$1.57B$1.59B$1.66B$1.74B$1.74B$1.49B$1.66B$1.96B$2.12B
Retained earnings$1.19B$1.23B$1.32B$1.41B$1.50B$1.59B$1.60B$1.71B$1.88B$2.04B
Shares (wtd avg diluted)67.8M67.9M67.7M64.8M63.6M63.0M61.4M61.2M61.4M60.5M

Every figure is extracted from TRUSTMARK CORP’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is TRUSTMARK CORP's free cash flow?
$232M in FY2025 (operating cash flow $244M minus $11.9M of capital expenditures), from the SEC cash-flow statement.
Does TRMK pay a dividend?
Yes — TRUSTMARK CORP paid $58.5M in cash dividends during FY2025, per its SEC cash-flow statement.
Full TRMK analysis — verdict, score & filings →Is TRMK a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.